JP2011529571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011529571A5 JP2011529571A5 JP2011520526A JP2011520526A JP2011529571A5 JP 2011529571 A5 JP2011529571 A5 JP 2011529571A5 JP 2011520526 A JP2011520526 A JP 2011520526A JP 2011520526 A JP2011520526 A JP 2011520526A JP 2011529571 A5 JP2011529571 A5 JP 2011529571A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- biological sample
- nds
- mci
- normal control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8515408P | 2008-07-31 | 2008-07-31 | |
| US61/085,154 | 2008-07-31 | ||
| PCT/EP2009/059951 WO2010012828A2 (en) | 2008-07-31 | 2009-07-31 | Glutaminyl cyclase as a diagnostic / prognostic indicator for neurodegenerative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011529571A JP2011529571A (ja) | 2011-12-08 |
| JP2011529571A5 true JP2011529571A5 (enExample) | 2012-09-20 |
| JP5677297B2 JP5677297B2 (ja) | 2015-02-25 |
Family
ID=41256108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011520526A Active JP5677297B2 (ja) | 2008-07-31 | 2009-07-31 | 神経変性疾患の診断／予後判定の指標としてのグルタミニルシクラーゼ |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20100028918A1 (enExample) |
| EP (1) | EP2329274B1 (enExample) |
| JP (1) | JP5677297B2 (enExample) |
| KR (1) | KR101682728B1 (enExample) |
| CN (2) | CN102112880B (enExample) |
| AU (1) | AU2009275869B2 (enExample) |
| BR (1) | BRPI0916601B1 (enExample) |
| CA (1) | CA2731933A1 (enExample) |
| EA (1) | EA025107B1 (enExample) |
| IL (1) | IL210266A (enExample) |
| MX (1) | MX2011001093A (enExample) |
| NZ (1) | NZ590658A (enExample) |
| SG (1) | SG193148A1 (enExample) |
| WO (1) | WO2010012828A2 (enExample) |
| ZA (1) | ZA201100177B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2789091A1 (en) * | 2010-02-18 | 2011-08-25 | Probiodrug Ag | Methods of diagnosing inflammatory diseases by determining pyroglutamate-modified mcp-1 and screening methods for inhibitors of glutaminyl cyclase |
| WO2012163773A1 (en) | 2011-05-27 | 2012-12-06 | Probiodrug Ag | Radiolabelled glutaminyl cyclase inhibitors |
| JP2018501482A (ja) | 2014-12-19 | 2018-01-18 | プロビオドルグ エージー | ｐＧｌｕ−Ａｂｅｔａペプチドの検出のための新規の方法 |
| CN104946680A (zh) * | 2015-06-11 | 2015-09-30 | 深圳大学 | 用于表达qc的重组载体及其制备方法、引物、基因工程菌 |
| JP6927212B2 (ja) * | 2016-07-08 | 2021-08-25 | 味の素株式会社 | 軽度認知障害又はアルツハイマー型認知症の評価方法 |
| KR102858457B1 (ko) * | 2023-06-07 | 2025-09-11 | 계명대학교 산학협력단 | Ccl8 단백질 또는 이를 코딩하는 유전자를 유효성분으로 포함하는 퇴행성 뇌질환 진단용 바이오마커 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4374316B2 (ja) * | 1993-01-25 | 2009-12-02 | 武田薬品工業株式会社 | β−アミロイドまたはその誘導体に対する抗体およびその用途 |
| JP3590468B2 (ja) * | 1996-01-22 | 2004-11-17 | 財団法人 東京都医学研究機構 | アルツハイマー病診断薬 |
| CA2487528A1 (en) | 2002-07-24 | 2004-02-12 | Innogenetics N.V. | Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation |
| US7732162B2 (en) * | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| NZ543146A (en) * | 2003-05-05 | 2008-09-26 | Probiodrug Ag | Use of effectors of glutaminyl cyclase (QC) activity in combination with inhibitors of DP IV or DP IV-like enzymes for the treatment of conditions that can be treated by modulation of QC-and/or DPIV-activity |
| KR20120007079A (ko) * | 2003-10-15 | 2012-01-19 | 프로비오드룩 아게 | 글루타미닐 및 글루타메이트 사이클라제 이펙터의 용도 |
| US20060094064A1 (en) * | 2003-11-19 | 2006-05-04 | Sandip Ray | Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| KR101099206B1 (ko) * | 2004-02-05 | 2011-12-27 | 프로비오드룩 아게 | 신규한 글루타미닐 시클라제 저해제 |
| US7592467B2 (en) * | 2005-04-11 | 2009-09-22 | Probiodrug Ag | Inhibitors of prolyl endopeptidase |
| ATE523788T1 (de) * | 2006-06-08 | 2011-09-15 | Fu Berlin | ASSAY ZUR DIAGNOSE VON ALZHEIMER BASIEREND AUF DER BESTIMMUNG DES VERHÄLTNISSES VON SEKRETASE-Aß-SPALTPRODUKTEN |
| NZ575727A (en) * | 2006-09-21 | 2011-12-22 | Probiodrug Ag | Novel genes related to glutaminyl cyclase |
| EP2121944B1 (en) * | 2007-01-19 | 2011-08-24 | Probiodrug AG | In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders |
-
2009
- 2009-07-31 KR KR1020117002132A patent/KR101682728B1/ko active Active
- 2009-07-31 SG SG2013056478A patent/SG193148A1/en unknown
- 2009-07-31 WO PCT/EP2009/059951 patent/WO2010012828A2/en not_active Ceased
- 2009-07-31 CA CA2731933A patent/CA2731933A1/en not_active Abandoned
- 2009-07-31 CN CN200980130500.4A patent/CN102112880B/zh active Active
- 2009-07-31 AU AU2009275869A patent/AU2009275869B2/en active Active
- 2009-07-31 EP EP09781358.8A patent/EP2329274B1/en active Active
- 2009-07-31 CN CN201410221835.XA patent/CN103983787A/zh active Pending
- 2009-07-31 JP JP2011520526A patent/JP5677297B2/ja active Active
- 2009-07-31 NZ NZ590658A patent/NZ590658A/en unknown
- 2009-07-31 US US12/533,099 patent/US20100028918A1/en not_active Abandoned
- 2009-07-31 EA EA201100253A patent/EA025107B1/ru not_active IP Right Cessation
- 2009-07-31 BR BRPI0916601-7A patent/BRPI0916601B1/pt active IP Right Grant
- 2009-07-31 MX MX2011001093A patent/MX2011001093A/es active IP Right Grant
-
2010
- 2010-12-26 IL IL210266A patent/IL210266A/en active IP Right Grant
-
2011
- 2011-01-06 ZA ZA2011/00177A patent/ZA201100177B/en unknown
-
2015
- 2015-03-12 US US14/645,821 patent/US20150247180A1/en not_active Abandoned
-
2016
- 2016-12-14 US US15/378,328 patent/US20170097365A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011529571A5 (enExample) | ||
| EP2768851B1 (en) | Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis | |
| US20170097365A1 (en) | Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseases | |
| EP2486407B1 (en) | A method for diagnosing primary biliary cirrhosis (pbc) using novel autoantigens | |
| US20110165600A1 (en) | Diagnosis method and diagnosis kit for dermatomyositis | |
| CN102203119B (zh) | 人儿茶酚-o-甲基转移酶(comt)测定 | |
| JP5568807B2 (ja) | プロテオミクス解析を用いたメラノーママーカーの同定 | |
| KR20220034709A (ko) | 주요 우울 장애 치료 효과 조기 예측용 바이오마커 | |
| JP2014224759A5 (enExample) | ||
| DK2391653T3 (en) | Biomarkers associated nephropathy | |
| JP2021170021A (ja) | 糖尿病性腎症の早期病態の特異的な診断を可能とする検査方法 | |
| JP2009155226A (ja) | 抗シトルリン化ｇｆａｐモノクローナル抗体及びその用途 | |
| Seferovic et al. | Quantitative 2-D gel electrophoresis-based expression proteomics of albumin and IgG immunodepleted plasma | |
| JP5961608B2 (ja) | ＥｐｈＡ４細胞外ドメインの測定による認知機能障害を伴う神経系疾患の検出方法 | |
| WO2020021026A1 (en) | Method of diagnosing asthma subtypes | |
| US8394639B2 (en) | Biomarkers for renal disease | |
| JP2011516840A5 (enExample) | ||
| US20190185530A1 (en) | Complex-specific standardization of immunological methods for the quantification of s100a12 | |
| WO2023275235A1 (en) | Method and means for diagnosis of spondyloarthritis | |
| KR20250142600A (ko) | 구강편평태선의 예후 예측을 위한 신규한 바이오마커 및 이의 용도 | |
| HK1155813B (en) | Glutaminyl cyclase as a diagnostic / prognostic indicator for neurodegenerative diseases | |
| HK1201538B (en) | Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |